{
    "2019-09-12": [
        [
            {
                "time": "2018-09-12",
                "original_text": "格隆汇港股聚焦(9.12)︱众安在线前8月原保费收入增近两成 复宏汉霖将于9月25日登陆港交所",
                "features": {
                    "keywords": [
                        "众安在线",
                        "复宏汉霖",
                        "港交所",
                        "原保费收入"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "保险",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "从合作办厂到全链条板块合作 外资药企的新“玩法”",
                "features": {
                    "keywords": [
                        "外资药企",
                        "全链条合作"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "复星医药(600196.SH)：复宏汉霖就在研产品HLX10拟授予Kalbe GeneXine在10个国家独家开展商业化 获支付至多6.82亿美元及销售提成",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复宏汉霖",
                        "HLX10",
                        "商业化合作"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "复星医药(02196.HK)就研产品HLX10签署许可条款书以加快拓展东南亚市场",
                "features": {
                    "keywords": [
                        "复星医药",
                        "HLX10",
                        "东南亚市场"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "复星医药(02196.HK)重组抗PD-1人源化单克隆抗体注射液联合化疗启动III期临床研究",
                "features": {
                    "keywords": [
                        "复星医药",
                        "PD-1",
                        "单克隆抗体",
                        "临床研究"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "复星医药(600196.SH)：HLX10联合化疗用于治疗未接受过治疗的广泛期小细胞肺癌启动III期临床研究",
                "features": {
                    "keywords": [
                        "复星医药",
                        "HLX10",
                        "小细胞肺癌",
                        "临床研究"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "复星医药(600196.SH)：复宏汉霖已刊发招股章程 H股发行价每股49.6港元-57.8港元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复宏汉霖",
                        "H股发行",
                        "招股章程"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "新商业模式会给未来的药企带来什么？",
                "features": {
                    "keywords": [
                        "新商业模式",
                        "药企"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "复宏汉霖——复星医药旗下创新药生物医药公司",
                "features": {
                    "keywords": [
                        "复宏汉霖",
                        "复星医药",
                        "创新药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "一致性评价进展分析：齐鲁双赢 苯磺酸氨氯地平片最热",
                "features": {
                    "keywords": [
                        "一致性评价",
                        "齐鲁制药",
                        "苯磺酸氨氯地平片"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "茅台们大跌：黄牛靠边，资金作祟",
                "features": {
                    "keywords": [
                        "茅台",
                        "大跌",
                        "黄牛",
                        "资金"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "逾30家A股公司计划分拆上市",
                "features": {
                    "keywords": [
                        "A股",
                        "分拆上市"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "早间公告：天业通联、中京电子重组事项近日上会",
                "features": {
                    "keywords": [
                        "天业通联",
                        "中京电子",
                        "重组"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}